HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Tyr(Me)-AVP

mediates postexercise reductions in arterial pressure (AP) and heart rate (HR)

Also Known As:

AVP-X

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Tyr(Me)-AVP: 6
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Tyr(Me)-AVP: 6
- Amino Acids: 30675
  - Cyclic Amino Acids: 3
    - Aromatic Amino Acids: 467
      - Tyrosine: 10509
        Tyr(Me)-AVP: 6

Experts

1.	Gu, Zhi-Xin: 1 article (04/2010)
2.	Li, Hui: 1 article (04/2010)
3.	Li, Xue-Ping: 1 article (04/2010)
4.	Lin, Bao-Cheng: 1 article (04/2010)
5.	Liu, Wen-Yan: 1 article (04/2010)
6.	Song, Cai: 1 article (04/2010)
7.	Song, Chao-You: 1 article (04/2010)
8.	Wang, Da-Xin: 1 article (04/2010)
9.	Wang, Gen: 1 article (04/2010)
10.	Yang, Jun: 1 article (04/2010)

Related Diseases

1.	Nephrogenic Diabetes Insipidus 01/01/2001 - "Nephrogenic diabetes insipidus (NDI) is characterized by resistance of the kidneys to the action of arginine vasopressin (AVP); X-linked recessive NDI is caused by an inactivating mutation of the vasopressin type-2 (V2) receptor. "
2.	Pain (Aches) 04/01/2010 - "The results showed that pain stimulation increased both AVP and Ach concentrations in the CdN perfusion liquid; AVP increased Ach concentration in the CdN perfusion liquid, while AVP receptor antagonist including d(CH(2))(5)Tyr(Me)AVP (V(1) receptor antagonist) and d(CH(2))(5)[D-Ile(2), Ile(4), Ala-NH(2)(9)]AVP (V(2) receptor antagonist) decreased Ach concentration in the CdN perfusion liquid. "
3.	Hypoglycemia (Reactive Hypoglycemia) 12/01/1990 - "We studied for the first time the AVP antagonist [d(CH2)5 Tyr(Me)AVP] in 6 normal men in order to evaluate the possible role of AVP as an ACTH-releasing hormone during insulin-induced hypoglycemia. "
4.	Hypertension (High Blood Pressure) 01/01/1984 - "In conscious rats with established deoxycorticosterone acetate (DOCA)/salt hypertension, d(CH2)5 Tyr (Me) AVP decreased systolic BP after acute administration. "
5.	Hypoxia (Hypoxemia) 10/01/1989 - "The second hypothesis was tested by injecting AVP (160 ng/kg) or vehicle intravenously in conscious hypoxia-adapted (4 weeks) or air control rats and measuring ANP in arterial blood and atria, and by testing pretreatment with the V1 receptor antagonist d(CH2)5 Tyr(Me)AVP (130 micrograms/kg) on the AVP-induced increase in plasma ANP. "

Related Drugs and Biologics

1.	Vasopressin Receptors (Arginine Vasopressin Receptor)
2.	Arginine Vasopressin (Argipressin)
3.	Desoxycorticosterone Acetate (DOCA)
4.	Vasopressins (Vasopressin)
5.	Salts
6.	Atrial Natriuretic Factor (ANF)
7.	Insulin (Novolin)
8.	Desoxycorticosterone (Deoxycorticosterone)
9.	Corticotropin-Releasing Hormone
10.	Acetates (Acetic Acid Esters)